Skip to main content
. 2021 Feb 24;8(3):ofab087. doi: 10.1093/ofid/ofab087

Table 2.

Clinical Outcomes of 421 Patients With Nontuberculous Mycobacterial Pulmonary Disease

Patients Without Cavity (n = 329) Patients With ≤2-cm-Sized Cavities (n = 48) Patients With >2-cm-Sized Cavities (n = 44) P Value
Follow-up duration, median (IQR), mo 49 (31–71) 41 (24–62) 51 (34–76) .212
Observed without treatment, No. (%) 211/329 (64.1) 17/48 (35.4) 11/44 (25.0) <.001
Spontaneous conversion in patients without treatment, No. (%)a 66/211 (31.3) 8/17 (47.1) 4/11 (36.4) .396
Treated with antibiotics, No. (%) 118/329 (35.9) 31/48 (64.6) 33/44 (75.0) <.001
Microbiological cure, No. (%)b 71/118 (60.2) 15/31 (48.4) 12/33 (36.4) .045

Abbreviation: IQR, interquartile range.

The denominators were patients who were observed without treatmenta and patients who were treated with antibiotics,b respectively.